Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A1 | Q14973 | 7/20 | 0.81 |
| ▸ | GPBAR1 | Q8TDU6 | 11/20 | 0.80 |
| ▸ | ABCC4 | O15439 | 4/20 | 0.80 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.80 |
| ▸ | SLC10A2 | Q12908 | 3/20 | 0.80 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.80 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.80 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.80 |
| ▸ | VDR | P11473 | 1/20 | 0.64 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurochenodeoxycholate Sulfate SCHEMBL1653685 | 1.00 | SLC10A1 (0.81) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL19360903 | 0.94 | GPBAR1 (0.82) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| Taurochenodeoxycholate SCHEMBL3125118 | 0.93 | GPBAR1 (0.80) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL19864132 | 0.93 | SLC10A1 (0.83) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL19864138 | 0.92 | SLC10A1 (0.81) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL19864174 | 0.92 | SLC10A1 (0.81) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL19364416 | 0.92 | SLC10A1 (0.76) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL25945786 | 0.92 | SLC10A1 (0.76) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL19360964 | 0.91 | SLC10A1 (0.94) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 | |
| SCHEMBL19364456 | 0.91 | SLC10A1 (0.94) | SLC10A1GPBAR1ABCC4NR1H4SLC10A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4352710-A1 | METHODS AND SYSTEMS FOR FACILITATING COLLECTION OF ROAD USER CHARGES USING A DIGITAL CURRENCY BASED ON A DISTRIBUTED LEDGER TECHNOLOGY | Lochrane, Taylor, William, Paul (US) | 2024-04-17 | — | — | EP | claimed |
| US-20220398870-A1 | METHODS AND SYSTEMS FOR FACILITATING COLLECTION OF ROAD USER CHARGES USING A DIGITAL CURRENCY BASED ON A DISTRIBUTED LEDGER TECHNOLOGY | LOCHRANE TAYLOR WILLIAM PAUL (US) | 2022-12-15 | — | — | US | claimed |
| WO-2022261465-A1 | METHODS AND SYSTEMS FOR FACILITATING COLLECTION OF ROAD USER CHARGES USING A DIGITAL CURRENCY BASED ON A DISTRIBUTED LEDGER TECHNOLOGY | LOCHRANE TAYLOR WILLIAM PAUL (US) | 2022-12-15 | — | — | WO | claimed |
| US-20250161686-A1 | MULTI-SITE NEUROMODULATION FOR TREATMENT OF ALS AND RELATED DISORDERS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2025-05-22 | — | — | US | disclosed |
| US-12208266-B2 | Multi-site neuromodulation for treatment of ALS and related disorders | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2025-01-28 | — | — | US | disclosed |
| US-20240416127-A1 | MODULATION OF NEURONAL NKCC1 AS A THERAPEUTIC STRATEGY FOR SPASTICITY AND RELATED DISORDERS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2024-12-19 | — | — | US | disclosed |
| US-11986659-B2 | Modulation of neuronal NKCC1 as a therapeutic strategy for spasticity and related disorders | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2024-05-21 | — | — | US | disclosed |
| EP-4352710-A1 | METHODS AND SYSTEMS FOR FACILITATING COLLECTION OF ROAD USER CHARGES USING A DIGITAL CURRENCY BASED ON A DISTRIBUTED LEDGER TECHNOLOGY | Lochrane, Taylor, William, Paul (US) | 2024-04-17 | — | — | EP | disclosed |
| EP-4347000-A1 | MULTI-SITE NEUROMODULATION FOR TREATMENT OF ALS AND RELATED DISORDERS | Research Foundation Of The City University Of New York (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022251165-A9 | MULTI-SITE NEUROMODULATION FOR TREATMENT OF ALS AND RELATED DISORDERS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2023-10-19 | — | — | WO | disclosed |
| CN-112326948-B | Biomarker for predicting diabetes, kit and using method thereof | 上海市内分泌代谢病研究所 | 2023-08-11 | — | — | CN | disclosed |
| CN-112326948-B | Biomarker for predicting diabetes, kit and using method thereof | 上海市内分泌代谢病研究所 | 2023-08-11 | — | — | CN | disclosed |
| US-11658745-B2 | Dispersion compensation | TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) (SE) | 2023-05-23 | — | — | US | disclosed |
| US-20220398870-A1 | METHODS AND SYSTEMS FOR FACILITATING COLLECTION OF ROAD USER CHARGES USING A DIGITAL CURRENCY BASED ON A DISTRIBUTED LEDGER TECHNOLOGY | LOCHRANE TAYLOR WILLIAM PAUL (US) | 2022-12-15 | — | — | US | disclosed |
| WO-2022261465-A1 | METHODS AND SYSTEMS FOR FACILITATING COLLECTION OF ROAD USER CHARGES USING A DIGITAL CURRENCY BASED ON A DISTRIBUTED LEDGER TECHNOLOGY | LOCHRANE TAYLOR WILLIAM PAUL (US) | 2022-12-15 | — | — | WO | disclosed |
| WO-2022251165-A1 | MULTI-SITE NEUROMODULATION FOR TREATMENT OF ALS AND RELATED DISORDERS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2022-12-01 | — | — | WO | disclosed |
| US-20220077930-A1 | DISPERSION COMPENSATION | TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) (SE) | 2022-03-10 | — | — | US | disclosed |